Pharmacovigilance in Latvia
How is it with the drug safety system in this Baltic state? Read our guide to get a clear picture.
And of course, if you feel you need a local consultant, we’re here for you.
Current status of our Latvian pharmacovigilance services:
LCPPV / EU QPPV in Latvia
AVAILABLE
Easily managed through Tepsivo Platform >
Local Literature Screening
AVAILABLE
Automated monitoring with Tepsivo Literature >
Who is the main PV authority in Latvia?
Other important institutions & industry groups
Some of the most important laws
Essential EU Legislation and EMA Guidlines
Since Latvia is a member of the EU, every Marketing Authorization Holder with a product on the Latvian market needs to follow the European pharmacovigilance legislation and guidelines by EMA (European Medicine Agency).
To navigate through the European regulations, its is useful to know following:
– EMA Pharmacovigilance System Manual
– Directive 2001/83/EC
– Regulation (EC) 726/2004
– Commission Implementing Regulation (EU) 520/2012
Local pharmacovigilance specifics
Useful abbreviations to know
If you want to study local materials about pharmacovigilance in Latvia, following terms will be helpful for you to get familiar with:
EMA (European Medicine Organization)
→ Key part of the EU, dedicated to ensuring the safety and effectiveness of medicines.
EVPM (EudraVigilance post-authorization module)
→ Dedicated to the collection of ICSRs related to all medicinal products authorised in the EEA.
PRAC (Pharmacovigilance Risk Assessment Committee)
→ Committee responsible for assessing and monitoring the safety of human medicines
ZVA (Zāļu valsts aģentūra)
→ State Agency of Medicines / Main authority on pharmacovigilance.
Is LCPPV needed or is EU QPPV enough?
How can be adverse events reported in Latvia?
Healthcare professionals and marketing authorization holders can submit reports electronically through the EudraVigilance system, more information here.
Patients and Healthcare professionals can use online reporting via forms linked here.
Local medical journals to screen
Here are few examples of Latvian local literature sources that medical authorization holders should monitor:
PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES
This peer-reviewed journal publishes original research and reviews across various scientific disciplines, including biological and medical sciences.
It serves as a platform for significant research findings from Latvia and beyond, making it essential for anyone, who is interested in the latest scientific advancements.
ISSN: 2255-890X
MATERIA MEDICA (only print)
Published by the Latvian Society of Pharmacists, this journal provides critical information on pharmacology and therapeutic practices and drug development.
It’s particularly useful for pharmacists looking to enhance their knowledge and practice standards.
ISSN: 1024-1590
LATVIJAS ĀRSTS
This national medical journal focuses on a wide range of health topics relevant to Latvian healthcare professionals.
It features articles that address both practical and theoretical aspects of medicine, making it an essential read for those involved in patient care.
ISSN: 1019-5068
DOCTUS
Aimed at physicians and pharmacists, DOCTUS offers insights into current medical practices, innovations, and continuing education.
It is a valuable resource for healthcare professionals seeking to stay updated on clinical guidelines and emerging therapies.
ISSN: 1407-821X
Rather then spending your budget for hours of repetitive manual work to monitor those sources, we recommend to simply automate this task using our Tepsivo Literature solution.
Other interesting resources
Country Public Health / Health System Assessments
Latvia: Country Health Profile 2023
The 2023 edition of “State of Health in the EU: Latvia” provides a comprehensive look at the health landscape in the country, exploring key topics such as overall health status, important health determinants and risk factors, and how the health system is organized and funded.
Publications by ZVA
ZVA’s annual reports can be found in About the agency, reports are sorted by year and each report can be downloaded as PDF document.
Book “Introduction in Pharmacovigilance”
The authors of this insightful book emphasize the importance of considering medication use as a potential factor in health disorders during diagnosis, highlighting how physicians’ observations can lead to safer medication practices and further research.
Baltic Statistics on Medicines 2016-2018
It provides a deep dive into medication consumption trends across Lithuania, Latvia, and Estonia over three years, marking its third edition since 2013. This comprehensive analysis not only highlights similarities in medicine use among the Baltic States but also features expert insights on how changes in reimbursement and treatment guidelines have influenced specific drug categories.
When you come across a pharmaceutical term in Lithuanian and want to be sure of the correct translation, visit this site.
Studies related to pharmacovigilance in Latvia
An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
This study compares the prevalence, regulations, and pharmacovigilance practices surrounding clozapine, revealing surprising insights, you’ll discover how clozapine prescription rates vary wildly and why improving monitoring practices is crucial for enhancing patient safety.
Do you need some help with putting the Latvian PV System together? We’re here for you.

And while you’re here…
…consider also our global end-to-end PV solution!
Thanks to the Tepsivo platform, you can get a full pharmacovigilance system in all countries you need – for a fraction of the usual budget.

Tepsivo Oy | Urho Kekkosen katu, 4-6 E, 00 100, Helsinki, Finland | VAT number FI31367614 | contact@tepsivo.com | +358 402 204 698 | Privacy policy